In the News | Charles River
   
 
 
   
   

Minimizing Cardiovascular Liabilities Throughout Drug Development
Drug Delivery Technology – October 2009

The various effects of pharmaceuticals on the cardiovascular system are currently a major topic of interest throughout the drug development industry. This cardiovascular focus is primarily due to the fact that drugs even those not specifically designed to directly affect cardiovascular function-can easily alter this fragile but vital organ system. As a result, specialized precautions must be taken throughout a drug discovery and development program. These precautions require the conduct of specific studies that can increase the overall complexity and require additional risk/benefit assessments. Potential cardiovascular toxicities can become more evident as a lead candidate enters the later stages of drug development...Read the full article.

   
Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

1.877.CRIVER.1 (1.877.274.8371)
askcharlesriver@crl.com

view all

News & Events

view all
May 14 - New Models for Evaluating COPD or ...
May 11 - Expert Safety Testing to Accelerat...
Jun 17-Jun 20 -  Noordwijk aan Zee, the Netherlands - 19th MDO Meeting / 12th European ...
Jun 02-Jun 05 - Vancouver, British Columbia - CALAS
Jun 05-Jun 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Biol...
Jun 05-Jun 08 - Saint Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA
Manager International Tax Wilmington, MA

Charles River Laboratories, Inc.